A Placebo-Controlled Study of Mirtazapine for PTSD

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2011

Study Completion Date

June 30, 2012

Conditions
AnxietyPTSD
Interventions
DRUG

Mirtazapine

Mirtazapine initiated at 15mg qhs and titrated in 15mg increments to a maximum of 45 mg qhs as tolerated.

DRUG

Placebo

Look-a-like placebo tablets under double-blind conditions

Trial Locations (1)

35405

Tuscaloosa VAMC, Tuscaloosa

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00302107 - A Placebo-Controlled Study of Mirtazapine for PTSD | Biotech Hunter | Biotech Hunter